Skip to content

LivaNova

US · LIVN #2263 by market cap Listed 1970
90.73 -1.34 -1.46%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Rating change
    KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $92
    Market Newswire · 2026/6/22
  • Rating change
    Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
    Market Newswire · 2026/9/2
  • Rating change
    Barclays Upgrades LivaNova(LIVN.US) to Buy Rating, Raises Target Price to $105
    Market Newswire · 2026/10/7
  • Rating change
    Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/4/13
  • Rating change
    Analysts' Opinions Are Mixed on These Healthcare Stocks: LivaNova (LIVN), Gain Therapeutics (GANX) and Tempus AI, Inc. Class A (TEM)
    TipRanks · 2026/7/2
  • Rating change
    Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Maintains Target Price $73
    Market Newswire · 2026/2/27
  • Barclays Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/11/9
  • Rating change
    Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $87
    Market Newswire · 2026/6/23
  • Rating change
    Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $93
    Market Newswire · 2026/8/6
  • Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Announces Target Price $115
    Market Newswire · 2026/11/5
  • Rating change
    A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $72 to $90
    Market Newswire · 2026/5/7
  • Rating change
    Baird Maintains LivaNova(LIVN.US) With Buy Rating, Cuts Target Price to $76
    Market Newswire · 2026/5/8
  • Rating change
    Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $90
    Market Newswire · 2026/5/8
  • Rating change
    Needham Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
    Market Newswire · 2026/3/19
  • Barclays Initiates LivaNova(LIVN.US) With Buy Rating, Announces Target Price $105
    Market Newswire · 2026/10/8
  • A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $105 to $120
    Market Newswire · 2026/11/5
  • Rating change
    Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $95
    Market Newswire · 2026/7/15
  • Rating change
    Mizuho Securities Maintains LivaNova(LIVN.US) With Buy Rating
    Market Newswire · 2026/8/21
  • Baird Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $111
    Market Newswire · 2026/11/5
  • Rating change
    A Quick Look at Today's Ratings for LivaNova(LIVN.US), With a Forecast Between $73 to $85
    Market Newswire · 2026/2/27
  • Rating change
    Needham Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $81
    Market Newswire · 2026/2/26
  • Rating change
    Stifel Maintains LivaNova(LIVN.US) With Buy Rating, Raises Target Price to $80
    Market Newswire · 2026/2/26
  • Rating change
    Goldman Sachs Maintains LivaNova(LIVN.US) With Hold Rating, Raises Target Price to $73
    Market Newswire · 2026/2/26
  • Rating change
    Piper Sandler Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $85
    Market Newswire · 2026/2/19
  • Rating change
    KeyBanc Maintains LivaNova(LIVN.US) With Buy Rating, Maintains Target Price $81
    Market Newswire · 2026/1/26

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

LivaNova discussion 0 comments

Add a comment